Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good

Long non-coding RNA as a potential diagnostic biomarker in head and neck squamous cell carcinoma: A systematic review and meta-analysis

Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty

Cancers, Free Full-Text

Tumor-derived lncRNAs: Behind-the-scenes mediators that modulate the immune system and play a role in cancer pathogenesis - ScienceDirect

Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives, Biomarker Research

The copious capabilities of non-coding RNAs in cancer regulation, diagnosis and treatment - ScienceDirect

The transcriptional landscape and diagnostic potential of long non-coding RNAs in esophageal squamous cell carcinoma

IJMS, Free Full-Text

PDF) Immune Modulatory Long-Non-Coding RNA as a Potential Therapeutic Target in Cancer

lncRNA modulated cell cycle regulators in cancer

ROC analysis suggests that genomic data (the 8-lncRNA signature and a

HAGLR, A Long Non-coding RNA of Potential Tumor Suppressive Function in Clear Cell Renal Cell Carcinoma: Diagnostic and Prognostic Implications